Notes in Breast Cancer

To Subscribe, use this Key

Status	Last Update	Fields
Published	02/18/2024	A1 Breast cancer pathology lecture part 2 day TWH 10/2019
Published	02/18/2024	A3 LABC systemic therapy - Phase 2 talk TWH 10/2019
Published	02/18/2024	Breast \| 1.1.2 \| Aetiology and risk factors
Published	02/18/2024	Breast \| 1.3 \| Microscopic anatomy
Published	02/18/2024	Breast \| 1.4 \| General breast pathology
Published	02/18/2024	Breast \| 1.5.1.1 \| Benign \| Epithelial \| Fibrocystic change (non-proliferative breast changes)
Published	02/18/2024	Breast \| 1.5.1.2 \| Benign \| Epithelial \| Proliferative breast disease without atypia
Published	02/18/2024	Breast \| 1.5.1.3 \| Benign \| Epithelial \| Proliferative breast disease with atypia
Published	02/18/2024	Breast \| 1.5.2.1 \| Benign \| Stromal \| Fibroadenoma
Published	02/18/2024	Breast \| 1.5.2.2 \| Benign \| Stromal \| Phyllodes
Published	02/18/2024	Breast \| 4.2.4.1 \| EBC \| Mastectomy \| PMRT \| Curie chest wall guidelines (from SC)
Published	02/18/2024	Breast \| 1.6 \| Pathways of breast cancer development
Published	02/18/2024	Breast \| 1.7.1 \| Pre-invasive (in-situ disease) \| Comparison table
Published	02/18/2024	Breast \| 1.8.1.2 \| Invasive carcinomas \| Summary of changes in 2019 WHO classifcaion
Published	02/18/2024	Breast \| 1.8.1.1 \| Invasive carcinomas \| Classification
Published	02/18/2024	Breast \| 1.1.1 \| Epidemiology
Published	02/18/2024	Breast \| 1.8.3.1 \| Invasive carcinomas \| Grading
Published	02/18/2024	Breast \| 1.8.4.1 \| Invasive carcinomas \| Infiltrating ductal carcinoma NOS (80%)
Published	02/18/2024	Breast \| 1.8.4.4 \| Invasive carcinomas \| Tubular carcinoma (1.5%-10%)
Published	02/18/2024	Breast \| 1.8.4.3 \| Invasive carcinomas \| Medullary carcinoma (5%)
Published	02/18/2024	Breast \| 1.8.4.2 \| Invasive carcinomas \| Invasive lobular carcinoma (5-8%)
Published	02/18/2024	Breast \| 1.8.4.5 \| Invasive carcinomas \| Mucinous (colloid) carcinoma (2%)
Published	02/18/2024	Breast \| 1.8.4.6 \| Invasive carcinomas \| Others (1-2%) \| Micropapillary carcinoma
Published	02/18/2024	Breast \| 1.8.4.7 \| Invasive carcinomas \| Others (1-2%) \| Papillary
Published	02/18/2024	Breast \| 1.8.4.8 \| Invasive carcinomas \| Others (1-2%) \| Metaplastic (<1%)
Published	02/18/2024	Breast \| 1.8.4.9 \| Invasive carcinomas \| Others (1-2%) \| Adenoid cystic (rare)
Published	02/18/2024	Breast \| 1.8.5.1 \| Invasive carcinomas \| Others (1-2%) \| Pagets disease
Published	02/18/2024	Breast \| 1.8.5.2 \| Invasive carcinomas \| Others (1-2%) \| Inflammatory carcinoma
Published	02/18/2024	Breast \| 1.7.2 \| Pre-invasive (in-situ disease) \| Ductal carcinoma in situ (DCIS)
Published	02/18/2024	Breast \| 1.7.3 \| Pre-invasive (in-situ disease) \| Lobular carcinoma in situ (LCIS)
Published	02/18/2024	Breast \| 1.9.1.1 \| Predictive biomarkers
Published	02/18/2024	Breast \| 1.8.6.1 \| Non-epithelial \| Sarcoma
Published	02/18/2024	Breast \| 1.8.6.2 \| Non-epithelial \| Primary breast lymphoma
Published	02/18/2024	Breast \| 1.9.1.2 \| Molecular subtyping
Published	02/18/2024	Breast \| 1.9.2.3 \| Multi-gene panels - Oncotype Dx, PAM50, Mammaprint, Endopredict, Breast Cancer Index
Published	02/18/2024	Breast \| 2.1 \| Screening
Published	02/18/2024	Breast \| 2.2.9 \| Hereditary breast cancer \| Genetic testing
Published	02/18/2024	Breast \| 2.2.3 \| Hereditary breast cancer \| BRCA gene mutations
Published	02/18/2024	Breast \| 2.2.1 \| Hereditary breast cancer \| List of syndromes implicated in hereditary breast cancer
Published	02/18/2024	Breast \| 2.2.4 \| Hereditary breast cancer \| CHEK2
Published	02/18/2024	Breast \| 2.2.5 \| Hereditary breast cancer \| Li-Fraumeni syndrome
Published	02/18/2024	Breast \| 2.2.6 \| Hereditary breast cancer \| Cowden syndrome
Published	02/18/2024	Breast \| 2.2.7 \| Hereditary breast cancer \| Peutz-Jeghers syndreom
Published	02/18/2024	Breast \| 2.2.8 \| Hereditary breast cancer \| Ataxia-telangiectasia
Published	02/18/2024	Breast \| 1.5.3.1 \| Inflammtory \| Fat necrosis
Published	02/18/2024	Breast \| 1.5.3.2 \| Inflammatory \| Duct ectasia
Published	02/18/2024	Breast \| 2.2.0 \| Hereditary breast cancer \| overview
Published	02/18/2024	Breast \| 2.3 \| Male breast cancer
Published	02/18/2024	Breast \| 2.4.1 \| Prognosis
Published	02/18/2024	Breast \| 2.4.2 \| Prognostic factors
Published	02/18/2024	Breast \| 3.1 \| Management \| Categories
Published	02/18/2024	Breast \| 3.2 \| Early breast cancer \| Factors affecting management
Published	02/18/2024	Breast \| 3.4.2 \| Prognostic factors \| In-breast recurrence (ASTRO)
Published	02/18/2024	Breast \| 3.3.1 \| Staging (AJCC 8th edition)
Published	02/18/2024	Breast \| 3.3.2 \| Staging \| Changes between AJCC 7th and 8th editions
Published	02/18/2024	Breast \| 3.5 \| Clinical presentation
Published	02/18/2024	Breast \| 3.6.1 \| Workup
Published	02/18/2024	Breast \| 3.6.2 \| Mammogram
Published	02/18/2024	Breast \| 3.6.3 \| Ultrasound
Published	02/18/2024	Breast \| 3.6.4 \| Percutaneous biopsy
Published	02/18/2024	Breast \| 1.2 \| Biologic behaviour
Published	02/18/2024	Breast \| 3.4.3 \| Prognosis by stage
Published	02/18/2024	Breast \| 3.4.1 \| Prognostic factors
Published	02/18/2024	Breast \| 4.1.1 \| EBC \| Management overview
Published	02/18/2024	Breast \| 4.2.1 \| EBC \| Mastectomy \| Types of mastectomy
Published	02/18/2024	Breast \| 4.2.2 \| EBC \| Mastectomy \| LN management
Published	02/18/2024	Breast \| 4.1.2 \| EBC \| BCS vs. Mastectomy
Published	02/18/2024	Breast \| 4.2.3 \| EBC \| Mastectomy \| Reconstruction
Published	02/18/2024	Breast \| 4.3.1.1 \| EBC \| BCT \| BCS
Published	02/18/2024	Breast \| 4.3.2.1.1 \| EBC \| BCT \| Adj RT \| Benefit
Published	02/18/2024	Breast \| 4.3.2.7.2 \| EBC \| BCT \| Adj RT \| Elderly \| T1N0 ER+ \| Omission of RT
Published	02/18/2024	Breast \| 4.3.2.7.3 \| EBC \| BCT \| Adj RT \| Elderly \| T1N0 ER+ \| Extreme hypofractionation
Published	02/18/2024	Breast \| 4.3.2.7.1 \| EBC \| BCT \| Adj RT \| Elderly \| T1N0 ER+ \| Overview
Published	02/18/2024	Breast \| 4.3.2.1.2 \| EBC \| BCT \| Adj RT \| Omission of adjuvant RT
Published	02/18/2024	Breast \| 4.3.2.2.1 \| EBC \| BCT \| Adj RT \| Moderate hypofractionation
Published	02/18/2024	Breast \| 4.3.2.3 \| EBC \| BCT \| Adj RT \| Extreme hypofractionation
Published	02/18/2024	Breast \| 4.3.2.2.2 \| EBC \| BCT \| Adj RT \| Moderate hypofractionation \| Regional nodes
Published	02/18/2024	Breast \| 4.2.4.2 \| EBC \| Mastectomy \| Adj RT (PMRT) \| Moderate hypofractionation
Published	02/18/2024	Breast \| 4.3.2.4 \| EBC \| BCT \| Adj RT \| Boost
Published	02/18/2024	Breast \| 4.3.2.5.1 \| EBC \| BCT \| Adj RT \| Accelerated partial breast irradiation (APBI) \| Overview
Published	02/18/2024	Breast \| 4.3.2.5.2 \| EBC \| BCT \| Adj RT \| APBI \| EBRT
Published	02/18/2024	Breast \| 4.3.2.5.3 \| EBC \| BCT \| Adj RT \| APBI \| Brachytherapy
Published	02/18/2024	Breast \| 4.3.2.5.4 \| EBC \| BCT \| Adj RT \| APBI \| IORT
Published	02/18/2024	Breast \| 4.3.2.6 \| EBC \| BCT \| Adj RT \| Partial breast irradiation (not accelerated)
Published	02/18/2024	Breast \| 4.2.4.0 \| EBC \| Mastectomy \| Adj RT (PMRT) \| Overview
Published	02/18/2024	Breast \| 4.4.1 \| EBC \| Regional LNs \| Lymphatic drainage of breast and risk of nodal involvement
Published	02/18/2024	Breast \| 4.4.2 \| EBC \| Regional LNs \| Assessment of the axilla
Published	02/18/2024	Breast \| 4.4.3 \| EBC \| Regional LNs \| Mx of outcomes from SLNBs
Published	02/18/2024	Breast \| 4.4.4 \| EBC \| Regional LNs \| Regional nodal volumes after BCS
Published	02/18/2024	Breast \| 4.4.5 \| EBC \| Regional LNs \| IMC
Published	02/18/2024	Breast \| 4.4.6 \| EBC \| Regional LNs \| SCF
Published	02/18/2024	Breast \| 4.4.6 \| EBC \| Regional LNs \| Toxicity of RNI
Published	02/18/2024	Breast \| 4.5.1 \| EBC \| Adjuvant chemotherapy
Published	02/18/2024	Breast \| 5.1 \| LABC \| Overview
Published	02/18/2024	Breast \| 5.2.1 \| LABC \| Systemic management \| Neoadjuvant chemotherapy
Published	02/18/2024	Breast \| 5.2.2 \| LABC \| Systemic management \| Adjuvant chemotherapy
Published	02/18/2024	Breast \| 5.2.3 \| LABC \| Systemic management \| Hormonal manipulation
Published	02/18/2024	Breast \| 5.2.4 \| LABC \| Systemic management \| Anti-Her2
Published	02/18/2024	Breast \| 6.1 \| Metastatic
Published	02/18/2024	Breast \| 7.1 \| Recurrent breast cancer
Published	02/18/2024	Breast \| 8.1 \| Inflammatory breast cancer
Published	02/18/2024	Breast \| 8.2 \| Paget's disease of the breast
Published	02/18/2024	Breast \| 8.3 \| Breast cancer in pregnancy
Published	02/18/2024	Breast \| 8.3 \| Male breast cancer
Published	02/18/2024	Breast \| 9.1 \| RT planning
Published	02/18/2024	Breast \| 9.2 \| Validation of ESTRO contouring guidlines
Published	02/18/2024	Breast \| 4.0 \| Management overview
Published	02/18/2024	Breast \| 1.8.3.2 \| Multifocal / Multicentric
Published	02/18/2024	Breast \| 4.3.2.5 \| EBC \| BCT \| Adj RT \| Techniques
Published	02/18/2024	Breast \| 4.3.2.7.3 \| EBC \| BCT \| Adj RT \| Omission of RT - EXPERT trial
Published	02/18/2024	Breast \| 4.3.2.4.2 \| EBC \| BCT \| Adj RT \| Simultaneous integrated boost
Status	Last Update	Fields